Cargando…
Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
BACKGROUND: Previous studies have demonstrated that PANoptosis is strongly correlated with cancer immunity and progression. This study aimed to develop a PANoptosis-related signature (PANRS) to explore its potential value in predicting the prognosis and immunotherapy response of hepatocellular carci...
Autores principales: | Zhu, Jinfeng, Huang, Qian, Peng, Xingyu, Luo, Chen, Liu, Zitao, Liu, Dongdong, Yuan, Huazhao, Yuan, Rongfa, Cheng, Xuexin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471990/ https://www.ncbi.nlm.nih.gov/pubmed/37662906 http://dx.doi.org/10.3389/fimmu.2023.1218661 |
Ejemplares similares
-
Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
por: Peng, Xingyu, et al.
Publicado: (2022) -
Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023) -
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
por: Yi, Xianyanling, et al.
Publicado: (2023) -
Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022) -
Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma
por: Xiong, Xiaofeng, et al.
Publicado: (2023)